Navigation Links
ADVENTRX Appoints Vice President of Manufacturing
Date:4/9/2008

on ADVENTRX's web site at http://www.adventrx.com.

Forward Looking Statement

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors that, if they do not materialize or prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that ADVENTRX will be unable to raise sufficient capital to fund the projects necessary to meet its anticipated or stated goals and milestones; the risk that preclinical results are not indicative of the success of subsequent clinical trials and the results of pending clinical trials; the potential for ADVENTRX's product candidates to receive regulatory approval for one or more indications on a timely basis or at all, and the uncertain process of seeking regulatory approval; other difficulties or delays in developing, testing, manufacturing, marketing and obtaining regulatory approval for ADVENTRX's product candidates; the potential for regulatory authorities to require additional preclinical work or other clinical requirements to support regulatory filings; the market potential for ADVENTRX's product candidates and ADVENTRX's ability to compete in those markets; the scope and validity of patent protection for ADVENTRX's product candidates; patent and non-patent exclusivity covering Navelbine(R) and Taxotere(R); and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at http://www.sec.gov.

You are cautioned not to place un
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer
2. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
3. ADVENTRX Pharmaceuticals to Report Fourth Quarter and Year End 2007 Results
4. Eric K. Rowinsky Joins ADVENTRX Board of Directors
5. ADVENTRX to Present Complete ANX-530 Pharmacokinetic Data at the 2008 American Association for Cancer Research Annual Meeting
6. ADVENTRX Announces Consolidation of Clinical and Management Positions
7. ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results
8. ADVENTRX Appoints Vice President of Commercialization
9. ADVENTRX Pharmaceuticals to Present at the 2007 BIOInvestor Forum
10. ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference
11. ADVENTRX Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013  Dr. Gerald Zon ... acid research, recently launched a new blog in conjunction ... ( zon.trilinkbiotech.com ), focuses on what,s trending in the ... industry thought leaders, discussions of research presented at conferences ... Dr. Zon (PhD Princeton University 1971) developed ...
(Date:5/20/2013)... May 20, 2013 With bed bugs' presence ... that although bed bugs need to be eliminated, one must ... compromise a person's health. And so to help bed bug ... get rid of bed bugs without using harmful ... bug spray it called Bed Bug Bully. , According to ...
(Date:5/20/2013)... CHAPEL HILL, N.C. , May 20, 2013 ... pharmaceutical company focused on developing differentiated antibiotics to ... bacterial infections, today announced that it presented data ... 2013) in Philadelphia demonstrating ... versus levofloxacin in Cempra,s prior Phase 2 clinical ...
(Date:5/20/2013)... 2013 Rhythm announced today the results of ... company,s novel ghrelin agonist for the treatment of diabetic ... that RM-131 significantly accelerates early gastric emptying and reduces ... with diabetic gastroparesis. The findings were presented at the ... and recently published in Clinical Gastroenterology ...
Breaking Biology Technology:Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 2Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 3
... FRANKFURT, Germany and LAUSANNE, Switzerland ... IMIDIA ("Innovative Medicines Initiative for,Diabetes"), a public private consortium ... launch of a project focusing on,pancreatic islet cell function ... to develop biomarkers and tools to pave the way,for ...
... CAMBRIDGE, England , June 14, 2010 Executives ... under,which O2h will provide Senexis with chemistry services to support a patent,filing ... disease modifying treatments for Alzheimer,s Disease. , ... Dr. Mark Treherne , CEO ...
... , NEW YORK and JERUSALEM , ... a privately held biopharma company, announced that it has ... safety and pharmacokinetics (PK) of its proprietary product Octreolin, ... administered orally. Octreolin demonstrated a PK profile similar ...
Cached Biology Technology:Launch of IMIDIA - An Innovative Medicines Initiative Project for Diabetes 2Launch of IMIDIA - An Innovative Medicines Initiative Project for Diabetes 3Launch of IMIDIA - An Innovative Medicines Initiative Project for Diabetes 4O2h Continues to Support Senexis to Support Patent Filing Senexis Limited 2Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 2Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 3Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 4Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 5Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 6Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 7Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 8Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 9
(Date:5/16/2013)... African-American adults living closer to a fast food restaurant ... who lived further away from fast food, according to ... Center, and this association was particularly strong among those ... published online in the American Journal of Public ... to a fast food restaurant, and among lower-income African-Americans, ...
(Date:5/16/2013)... a gene involved in neurodegenerative disease also plays a ... clock. , In a study of the common ... keeps the clock responsible for sleeping and waking on ... the fruit fly,s sleep-wake cycle is disturbed, making waking ... , The discovery is particularly interesting because mutations ...
(Date:5/16/2013)... the cellular layer lining the body,s blood vessels, ... nanometers in thickness, this super-tenuous structure routinely withstands ... to create a unique and highly dynamic barrier ... from the body,s circulatory system. , It,s also ... be physically breached to enable immune cells ...
Breaking Biology News(10 mins):Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3Gene involved in neurodegeneration keeps clock running 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4
... Alexandria, Va. The American Association for Dental Research ... AADR Neal W. Chilton Fellowship in Clinical Research recipient. ... & Exhibition in Washington, DC, March 3, 2010. ... associate director of the Delta Dental of Kentucky Clinical ...
... Foundation has awarded a $630,100 project support grant ... support the initial implementation this year of a ... for primary care providers, technical staff and health ... Building Blocks (HIBBs), a program developed by AMIA ...
... Lori Marino will speak on the anatomical basis of dolphin ... conference (AAAS) in San Diego, on Sunday, Feb. 21 at ... than our own and second in mass to the human ... leading expert in the neuroanatomy of dolphins and whales, Marino ...
Cached Biology News:Rockefeller Foundation supports expansion, training of e-health work force in developing world 2Rockefeller Foundation supports expansion, training of e-health work force in developing world 3
Rabbit polyclonal to hCG ( Abpromise for all tested applications). entrezGeneID: 1081 SwissProtID: P01215...
Anti-Indolamine (Indoleamine) 2,3-dioxygenase Immunogen: Recombinant human IDO. Available Date: 38454...
Glutathione Agarose Beads 10 ml...
...
Biology Products: